Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-22 4:06 pm Purchase | 13G | Nuo Therapeutics Inc. AURX | Jacobs Paul Anthony | 2,800,000 6.000% | 300,000 (+12.00%) | View |
| 2024-02-14 1:58 pm Purchase | 13G | Nuo Therapeutics Inc. AURX | Jacobs Paul Anthony | 2,500,000 5.650% | 2,500,000 (New Position) | View |
| 2024-02-12 5:33 pm Sale | 13G | Nuo Therapeutics Inc. AURX | Flynn James E | 2,183,164 5.160% | -516,836 (-19.14%) | View |
| 2023-12-20 2:18 pm Sale | 13D | Nuo Therapeutics Inc. AURX | Pittman Scott M. | 5,401,054 12.100% | -519,301 (-8.77%) | View |
| 2022-07-05 08:02 am Purchase | 13D | Nuo Therapeutics Inc. AURX | SHEEDY CHARLES E | 13,098,497 39.000% | 1,908,820 (+17.06%) | View |
| 2022-07-05 08:01 am Purchase | 13D | Nuo Therapeutics Inc. AURX | Pittman Scott M. | 5,920,355 18.600% | 1,814,555 (+44.19%) | View |
| 2022-07-05 08:01 am Purchase | 13D | Nuo Therapeutics Inc. AURX | JORDEN DAVID EMERSON | 2,809,740 8.900% | 2,809,740 (New Position) | View |
| 2020-10-09 3:29 pm Purchase | 13G | Nuo Therapeutics Inc. AURX | Flynn James E | 2,700,000 9.240% | 2,700,000 (New Position) | View |